B. Riley Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,308
Closed -$202K 1104
2025
Q2
$202K Sell
2,308
-1,408
-38% -$110K 0.01% 898
2025
Q1
$254K Sell
3,716
-1,280
-26% -$104K 0.01% 1052
2024
Q4
$389K Sell
4,996
-594
-11% -$44K 0.01% 777
2024
Q3
$370K Buy
5,590
+1,662
+42% +$136K 0.01% 852
2024
Q2
$445K Buy
3,928
+162
+4% +$20.5K 0.01% 867
2024
Q1
$351K Buy
3,766
+2,143
+132% +$269K 0.01% 968
2023
Q4
$201K Sell
1,623
-2,143
-57% -$219K 0.01% 1259
2023
Q3
$351K Sell
3,766
-37,698
-91% -$4.25M 0.01% 968
2023
Q2
$5.33M Buy
41,464
+36,219
+691% +$4.38M 0.12% 174
2023
Q1
$609K Sell
5,245
-2,678
-34% -$300K 0.02% 729
2022
Q4
$763K Buy
7,923
+2,795
+55% +$307K 0.02% 636
2022
Q3
$414K Buy
5,128
+693
+16% +$58.7K 0.01% 842
2022
Q2
$332K Buy
4,435
+315
+8% +$28.7K 0.01% 831
2022
Q1
$528K Buy
4,120
+616
+18% +$67.4K 0.02% 721
2021
Q4
$471K Sell
3,504
-56
-2% -$8.05K 0.01% 839
2021
Q3
$459K Buy
3,560
+640
+22% +$80.7K 0.01% 817
2021
Q2
$312K Sell
2,920
-2,356
-45% -$226K 0.01% 1004
2021
Q1
$474K Buy
+5,276
New +$495K 0.02% 760
2020
Q3
Sell
-8,916
Closed -$904K 954
2020
Q2
$904K Buy
+8,916
New +$798K 0.06% 296

Other funds holding DXCM

B. Riley Wealth Advisors's DXCM Position: Q3 2025 in Review

B. Riley Wealth Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,308 shares — an estimated $202K sold.

B. Riley Wealth Advisors first reported a position in DXCM in Q2 2020 and held it in 19 quarters. The position peaked at $5.33M in Q2 2023. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • B. Riley Wealth Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,308 DexCom shares in Q3 2025, an estimated $202K.
  • B. Riley Wealth Advisors first reported a position in DexCom in Q2 2020 and held it in 19 quarters.
  • B. Riley Wealth Advisors's DexCom position peaked at $5.33M in Q2 2023.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.